# Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)

> **NCT05277311** · NA · UNKNOWN · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 1376 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** LongShengZhi capsule
- **DRUG:** LongShengZhi capsule placebo

## Key facts

- **NCT ID:** NCT05277311
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 1376 (ESTIMATED)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05277311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05277311, "Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05277311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*